Loading clinical trials...
Loading clinical trials...
Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment
Conditions
Interventions
Enzalutamide
Locations
2
United States
UCSF Medical Center-Mount Zion
San Francisco, California, United States
OHSU Knight Cancer Institute
Portland, Oregon, United States
Start Date
February 5, 2014
Primary Completion Date
October 1, 2019
Completion Date
July 8, 2024
Last Updated
September 19, 2024
NCT04693377
NCT05398302
NCT06526299
NCT04550494
NCT06705686
NCT06305598
Lead Sponsor
OHSU Knight Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions